Laboratorios Farma | ROVI - 税前利润

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.01B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	税前利润	更改		日
Akebia Therapeutics	USD -11.24M		12.39M	2025-12
Alaunos Therapeutics	USD -7.84M		633K	2023-12
Almirall	EUR 30.32M		22M	2025-12
Avita Medical	AUD -11.64M		12.13M	2025-12
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Ionis Pharmaceuticals	USD -93M		135M	2026-03
IQVIA Holdings	USD 6.22B		5.68B	2026-03
Laboratorios Farma	EUR 26.78M		94.77M	2025-06
Moderna	USD -799M		612M	2025-12
Organon & Co	USD -148M		391M	2025-12
Pharma Mar	EUR 1.6M		38.6M	2026-03
Revvity	USD 91.56M		35.88M	2025-12
Tectonic Therapeutic	USD -18.97M		63K	2025-12
Viatris	USD -343M		335.1M	2025-12
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12